COMMUNIQUÉS West-GlobeNewswire

-
Ultragenyx to Present at Bank of America Merrill Lynch Healthcare Conference
10/05/2019 -
Intercept Pharmaceuticals Announces Pricing of Offerings of Common Stock and Convertible Senior Notes due 2026
10/05/2019 -
Cormedix Announces Presentation of LOCK-IT-100 Study Results at National Kidney Foundation Spring 2019 Meeting
10/05/2019 -
Genetic Technologies Limited (ASX Code: GTG; NASDAQ Ticker: GENE) announces successful completion of two new ground-breaking Genetic Risk Tests – for Colorectal Cancer and for Breast Cancer
10/05/2019 -
Bladder Cancer Canada celebrates ten years
10/05/2019 -
Cancer de la vessie Canada célèbre son 10e anniversaire
10/05/2019 -
Galectin Therapeutics Releases Richard E. Uihlein’s Open Letter to Stockholders Dated May 10, 2019
10/05/2019 -
Forty Seven Inc. and Acerta Enter Collaboration to Evaluate Novel Immuno-Oncology Triple Combination in Diffuse Large B-cell Lymphoma
10/05/2019 -
Allscripts to present at Bank of America Merrill Lynch 2019 Healthcare Conference
10/05/2019 -
Galectin Therapeutics Reports Q1 2019 Financial Results and Provides Business Update
10/05/2019 -
Immutep Announces Upcoming Industry Conference Participation
10/05/2019 -
Crown Bioscience annonce une expansion de son site de San Diego, en Californie
10/05/2019 -
Flexion Therapeutics Announces Publication of Pooled Analysis of Phase 2/3 Data on Use of Rescue Medication with ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
10/05/2019 -
Wave Life Sciences Reports First Quarter 2019 Financial Results and Provides Business Update
10/05/2019 -
Acasti Settles Claims with Former Chief Executive Officer
10/05/2019 -
Mustang Bio Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
10/05/2019 -
Fortress Biotech Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
10/05/2019 -
Organogenesis Holdings Inc. Reports First Quarter 2019 Financial Results
10/05/2019 -
MediPharm Labs Announces Q1 2019 Revenue of $22 Million and Adjusted EBITDA of $4.3 Million
10/05/2019
Pages